Rotating Pazopanib and Everolimus No Extra Help in Renal Cancer Rotating Pazopanib and Everolimus No Extra Help in Renal Cancer

Alternating treatment with pazopanib and everolimus offers no advantages over continuous pazopanib in patients with metastatic clear cell renal cell cancer, according to Dutch researchers.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news